I fell in love with this place nearly 20 years ago because it reminded me of a premier venture capital firm. I draw this analogy because Damon Runyon has been associated with almost every breakthrough in cancer research despite the fact that we only grant around $18-20 million a year - tiny player, enormous impact."


Andrew S. Rachleff

Palo Alto, California

* Indicates member serves on the Scientific Committee

Vice Chair, Scientific Programs

William G. Kaelin, Jr., MD*
Sidney Farber Professor of Medicine
Dana-Farber Cancer Institute and
Harvard Medical School
Howard Hughes Medical Institute Investigator
Boston, Massachusetts


Vice Chair, Investments and Treasurer

David G. Marshall
Chairman and Chief Executive Officer
Amerimar Realty Company
Philadelphia, Pennsylvania



Vice Chair, Audit and Secretary

Sanford W. Morhouse, Esq.
Of Counsel
Schulte Roth & Zabel LLP
New York, New York



Receiving a Damon Runyon Fellowship had a tremendous impact on my scientific career. I also have been fortunate to mentor new Damon Runyon scientists in my lab who have gone on to have exemplary independent careers. Damon Runyon builds generations of scientific leaders and mentors.”

Elaine V. Fuchs, PhD

(Damon Runyon Fellow ‘77-‘79)

Vice Chair

David M. Beirne
General Partner
X10 Capital
San Francisco, California

Vice Chair

Michael L. Gordon*
New York, New York

Carlos L. Arteaga, MD*
Director of the Harold C. Simmons Comprehensive Cancer Center
Associate Dean of Oncology Programs
Professor of Medicine
The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology
University of Texas Southwestern Medical Center
Dallas, Texas

Steven J. Burakoff, MD*
Dean for Cancer Innovation
Director Emeritus, The Tisch Cancer Institute
Chief, Division of Pediatric Hematology and Oncology
Lillian and Henry M. Stratton Professor of
Professor of Medicine
Professor of Oncological Sciences
Cancer Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Melissa L. Cohn
Regional Vice President
William Raveis Mortgage LLC
Delray Beach, FL

Deborah J. Coleman*
Boston, Massachusetts

Robyn Coles
TRATE Properties LLC
Boston, Massachusetts

Gary E. Erlbaum
Greentree Properties
Ardmore, Pennsylvania


Buck French
General Partner
X10 Capital
San Francisco, California

Elaine V. Fuchs, PhD*
Head, Laboratory of Mammalian Cell Biology and Development
Rebecca C. Lancefield Professor
The Rockefeller University
Howard Hughes Medical Institute Investigator
New York, New York

Levi A. Garraway,
MD, PhD*

Executive Vice President
Chief Medical Officer and Head of Product Development
Genentech/Roche, Inc.
South San Francisco, California

Damon Runyon is one of the most successful and impactful organizations when it comes to support of the next generation of leaders in cancer research. Our ability to advance the understanding and treatment of cancer depends on the intellectual creativity and firepower of the people doing the research, so I wanted to be a part of ensuring that this organization can continue and grow its remarkable impact.”

Levi A. Garraway, MD, PhD

Richard B. Gaynor, MD*
President and Chief of Research and Development
BioNTech US
Cambridge, Massachusetts





Erica Evans Gioffre
Head of Client Engagement
Hirtle, Callahan & Co.





Todd R. Golub, MD*
Director and Founding Core Institute Member
Broad Institute of MIT and Harvard
Charles A. Dana Investigator in Human Cancer Genetics
Dana-Farber Cancer Institute
Professor of Pediatrics
Harvard Medical School
Cambridge, Massachusetts

David A. Gordon, PhD
Bridgewater Associates
Westport, CT




Scott Greenstein
President and Chief Content Officer
New York, New York




Morana Jovan-Embiricos, PhD*
Managing Partner
F2 Capital Ventures LLP
London, United Kingdom

Steven A. Kandarian
Chairman, President and Chief Executive Officer (Retired)
MetLife, Inc
North Palm Beach, Florida

Noah Knauf
General Partner
Bond Capital
San Francisco, California

Gabrielle Layton, PhD
Palo Alto, California

Gerald M. Marshall
President & CEO, Netrality Data Centers
Chairman & CEO, Amerimar Enterprises, Inc.
Miami Beach, FL

Richard W. Meier
The Bakewell Foundation
St. Louis, Missouri

John H. Myers
President (retired)
GE Asset Management
Fairfield, Connecticut

Richard J. O’Reilly, MD*
Claire L. Tow Chair, Pediatric Oncology Research
Memorial Sloan Kettering Cancer Center
New York, New York

Joseph Pearlberg, MD, PhD
Vice President of Scientific Affairs, Therapeutics
Deerfield Management Company
New York, New York

Lori J. Pierce, MD*
Professor, Radiation Oncology
Vice Provost for Academic and Faculty Affairs
University of Michigan
Rogel Cancer Center
Ann Arbor, MI

Adam R. Schwartz
Co-Managing Partner
TPG Angelo Gordon
New York, NY

Michael V. Seiden, MD, PhD*
Chief Executive Officer and Co-founder

Gladius Therapeutics

The Woodlands, Texas

Karen D. Seitz
Founder and Managing Director
Fusion Partners Global LLC
New York, New York

Nancy Simonian, MD*
Chief Executive Officer
Syros Pharmaceuticals, Inc.
Cambridge, Massachusetts

Amoolya Singh, PhD
Chief Scientific Officer
Senior Vice President of Data Science

Cynthia Sulzberger
Wellington, Florida

Judy C. Swanson
Hillsborough, California

Peter Van Camp
Executive Chairman
Equinix, Inc.
Redwood City, California

James A. Wells, PhD*
Harry Wm. and Diana V. Hind
Distinguished Professor in Pharmaceutical Sciences
Professor, Department of Pharmaceutical Chemistry
University of California, San Francisco
San Francisco, California

Yung S. Lie, PhD
President and Chief Executive Officer
Damon Runyon Cancer Research Foundation
New York, New York